Friday, April 21, 2017 12:59:24 PM
By ex-US collaboration, I wasn't referring to MighTy actually. I think there will be a partnership with someone like Roche on something like head and neck cancer. That's where I'm guessing we will see a big inflection point in terms of share price this year.
Interim data from the registration trial could also really help the stock if the first 23 real non-responders show a 30% response in Q4. It is possible that the "secure licensing & commercial partnerships" milestone could be referring to the registration trial and possible $ deal with MRK. But seems more likely to me at least that the milestone could be hinting more at an ex-US partnership.
Recent ONCSQ News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 07:30:19 PM
FEATURED DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • Nov 7, 2024 2:16 PM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • SBC • Nov 7, 2024 7:00 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM